The Australian Snoring & Nasal Breathing Report 2026

Why we wrote this

Snoring is one of the most googled health topics in Australia, but most of the content people land on is either thinly-disguised advertising or American medical articles that ignore Australian healthcare reality. We wanted a single citable resource that pulls together what the published research actually says, presented in plain English, with sources you can verify.

Nothing in this report is original RhinoGear research. Every figure is drawn from peer-reviewed journals, the Australian Bureau of Statistics, the Sleep Health Foundation or the Australasian Sleep Association. We've simply put them in one place and translated the jargon.

How common is snoring in Australia?

Population-level Australian data on habitual snoring is surprisingly thin, but the most cited figures from the Sleep Health Foundation's national surveys put habitual snoring (three or more nights a week) at roughly 40% of adult men and 25% of adult women, rising sharply after age 45 and with body-mass index above 27.

Obstructive sleep apnoea — where the airway repeatedly collapses, not just vibrates — affects an estimated 1 in 5 Australian adults at a clinically meaningful level (Adult Sleep Apnoea Survey, Sleep Health Foundation). Most cases remain undiagnosed because the symptoms (daytime fatigue, morning headache, irritability) are blamed on lifestyle, not airway.

• ~40% of adult Australian men snore habitually.
• ~25% of adult Australian women snore habitually.
• ~20% of all Australian adults meet criteria for obstructive sleep apnoea.
• Most undiagnosed sleep apnoea sits in the mild-to-moderate band — the band where conservative interventions still work.

Where does the noise actually come from?

Snoring is the sound of soft tissue vibrating in a narrowed airway. The narrowing can be at any of three levels: the nose (turbinates, septum, external nasal valve), the soft palate and uvula, or the base of the tongue.

Sleep ENT studies using drug-induced sleep endoscopy consistently show that a meaningful share of snorers have a primary nasal component. When that component is treated (allergy control, mechanical dilation, septal correction), throat-level snoring often improves as well — because the sleeper stops compensating with mouth-breathing.

What the evidence supports for nasal-origin snoring

• External nasal dilator strips: multiple randomised trials show 17–30% reductions in nasal airflow resistance and meaningful reductions in self-reported and partner-reported snoring intensity in adults whose snoring originates in the nasal valve.
• Intranasal corticosteroid sprays (fluticasone, mometasone): well-evidenced for allergic rhinitis-driven snoring; takes 2–4 weeks to reach full effect.
• Gentle mouth tape (vertical centre strip, leaving lip corners free): emerging evidence supports it as an adjunct to nasal-breathing training in healthy adults without sleep apnoea; it is not a treatment for OSA.
• Positional therapy (side-sleeping aids): well-evidenced for positional snorers and mild positional OSA.
• Weight reduction of 5–10% body weight: among the strongest single interventions for snoring and mild-to-moderate OSA.

What the evidence does not support

• 'Anti-snoring' wristbands that shock the wearer — no robust evidence of meaningful reduction in apnoea-hypopnoea index.
• Aromatherapy nasal sprays marketed as cures — no replicated trials showing effect on snoring or apnoea.
• Mouth tape as a treatment for diagnosed obstructive sleep apnoea — should not be used as a substitute for CPAP, mandibular advancement or surgical assessment.
• 'Snoring pillows' as a stand-alone treatment for non-positional snorers.

When to see a sleep physician

Self-treating habitual snoring with conservative measures (nasal strips, allergen control, side-sleeping, weight loss, gentle mouth tape) is reasonable for healthy adults with no warning signs. But certain symptoms should always prompt a referral to a GP for a sleep-study referral.

• Witnessed apnoeas (your partner sees you stop breathing).
• Loud snoring with daytime sleepiness severe enough to affect driving or work.
• Morning headaches, dry mouth, or unrefreshing sleep most days.
• Reflux, atrial fibrillation, treatment-resistant hypertension, or BMI over 35.
• Children who snore loudly every night — paediatric snoring should always be assessed.

The 2026 RhinoGear reader poll

We asked 1,238 Australian RhinoGear customers in February 2026 about their snoring history and what had — and had not — worked for them. The poll was anonymous and not designed as a clinical study; treat the figures as directional, not definitive.

• 62% reported a partner had complained about their snoring at least weekly before trying any intervention.
• 48% had previously tried over-the-counter decongestant sprays; 71% of those had stopped within two weeks because of rebound congestion.
• 84% of regular nasal-strip users reported reduced partner complaints within the first month.
• Only 9% had ever been offered a sleep study by their GP.
• Top three reasons users said they preferred drug-free options: avoiding medication side-effects (54%), partner pressure (38%), and dislike of CPAP (24%).

We will share the underlying anonymised dataset with any Australian academic researcher on request — email Support@rhinogear.com.au.

Sources & further reading

• Sleep Health Foundation — Asleep on the Job (2017) and Adult Sleep Apnoea Survey.
• Australasian Sleep Association — clinical practice guidelines for OSA.
• Australian Institute of Health and Welfare — Sleep problems as a risk factor for chronic conditions (2021).
• Petruson B et al. — Effect of external nasal dilator on snoring and apnoea (Acta Otolaryngol).
• Lee S-H et al. — Mouth taping for primary snoring: a randomised crossover trial (Healthcare 2022).
• American Academy of Sleep Medicine — clinical practice parameters for OSA.

Reuse this report

Journalists, academics, clinicians and content creators are welcome to cite, link to or quote this report freely. A link back to this page is appreciated but not required. Please do not paywall or republish the full text without permission.

For interview requests, dataset access or co-authored follow-ups, email Support@rhinogear.com.au.